
CL075
CAS No. 256922-53-9
CL075( —— )
Catalog No. M34210 CAS No. 256922-53-9
CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 52 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCL075
-
NoteResearch use only, not for human use.
-
Brief DescriptionCL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN).
-
DescriptionCL075 (3M002) is a selective TLR8 agonist with immunomodulating properties. CL075 triggers a MyD88-dependent signaling pathway to elicit production of inflammatory cytokines and type I interferons (IFNs) via activation of NF-κB and IRF7, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB | MyD88 | TLR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number256922-53-9
-
Formula Weight243.33
-
Molecular FormulaC13H13N3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 22 mg/mL (90.41 mM; 超声加热助溶)
-
SMILESCCCc1nc2c(N)nc3ccccc3c2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lai CY, et, al. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7. Vaccine. 2014 Sep 29;32(43):5593-9.?
molnova catalog



related products
-
L6H21
L6H21 is an MD-2 inhibitor that can be used to study cognitive impairment and brain damage.
-
Tomatidine
Tomatidine decreases inducible NO synthase and COX-2 expression through suppression of I-κBα phosphorylation, NF-κB nuclear translocation and JNK activation, which in turn inhibits c-jun phosphorylation and Oct-2 expression.
-
IT-901
IT-901 is a novel potent, small molecule inhibitor of NF-κB subunit c-Rel.